1 |
Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics.
62
57
5
|
De Rocco D...Savoia A
|
24326104 |
2014 |
2 |
A novel CYCS mutation in the α-helix of the CYCS C-terminal domain causes non-syndromic thrombocytopenia.
57
5
|
Uchiyama Y...Mizuguchi T
|
30051457 |
2018 |
3 |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
57
5
|
Morison IM...Ledgerwood EC
|
18345000 |
2008 |
4 |
GoldVariants, a resource for sharing rare genetic variants detected in bleeding, thrombotic, and platelet disorders: Communication from the ISTH SSC Subcommittee on Genomics in Thrombosis and Hemostasis.
5
|
Megy K...Freson K
|
34355501 |
2021 |
5 |
Congenital thrombocytopenia and cytochrome C mutation: a matter of birth and death.
5
|
Cramer Borde E...Morison IM
|
22102269 |
2011 |
6 |
Blockade of alpha2-adrenergic receptors in the caudal raphe region enhances the renal sympathetic nerve activity response to acute intermittent hypercapnia in rats.
62
|
Madirazza K...Dogas Z
|
35043650 |
2022 |
7 |
Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis.
62
|
Plattel WJ...von Tresckow B
|
34323643 |
2021 |
8 |
Low-affinity immunoglobulin gamma Fc region receptor III-B (FcγRIIIB, CD16B) deficiency in patients with blood and immune system disorders.
62
|
Minguela A...Campillo JA
|
34544201 |
2021 |
9 |
Influence of cysteine-directed mutations at the Ω-loops on peroxidase activity of human cytochrome c.
62
|
Samsri S...Pornsuwan S
|
34224685 |
2021 |
10 |
Benefits of immunoglobulin substitution in primary and secondary immunodeficiencies: Interim analysis of a prospective, long-term non-interventional study.
62
|
Bauhofer A...Klausmann M
|
33860753 |
2021 |
11 |
The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies.
62
|
Shaw JL...Soff GA
|
33544940 |
2021 |
12 |
Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience.
62
|
Stoetzer O...Salat C
|
34012372 |
2021 |
13 |
Real-world adverse events associated with CAR T-cell therapy among adults age ≥ 65 years.
62
|
Zettler ME...Gajra A
|
32798213 |
2021 |
14 |
A Novel Heterozygous Pathogenic Variation in CYCS Gene Cause Autosomal Dominant Non-Syndromic Thrombocytopenia 4 in a Large Chinese Family.
62
|
Che F...Yang Y
|
35126455 |
2021 |
15 |
FOLFIRINOX for Recurrent Pancreatic Cancer After Pancreatic Resection: A Secondary Analysis of the Nationwide Multicenter Observational Study Conducted by the Japan Adjuvant Study Group of Pancreatic Cancer 06.
62
|
Morinaga S...Fukutomi A
|
33122527 |
2020 |
16 |
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer.
62
|
Aggarwal RR...Alumkal JJ
|
32694156 |
2020 |
17 |
Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.
62
|
Franceschi E...Brandes AA
|
32787805 |
2020 |
18 |
A new piroplasmid species infecting dogs: morphological and molecular characterization and pathogeny of Babesia negevi n. sp.
62
|
Baneth G...Aroch I
|
32312309 |
2020 |
19 |
Phase II study of bevacizumab, cisplatin, and pemetrexed in advanced non-squamous non-small cell lung cancer (NS-NSCLC) with EGFR wild-type.
62
|
Murakami S...Yamada K
|
31881129 |
2019 |
20 |
Naturally Occurring A51V Variant of Human Cytochrome c Destabilizes the Native State and Enhances Peroxidase Activity.
62
|
Lei H...Bowler BE
|
31557440 |
2019 |
21 |
Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study.
62
|
Endo Y...Kitagawa Y
|
31420046 |
2019 |
22 |
Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer.
62
|
Heck MM...Eiber M
|
30473431 |
2019 |
23 |
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.
62
|
Oudard S...Elaidi R
|
30703190 |
2019 |
24 |
Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non-small-cell lung cancer.
62
|
Laslett NF...Guarino M
|
29905018 |
2018 |
25 |
Combined Fluoroscopy and Ultrasound-Guided Transjugular Kidney Biopsy in Cirrhotic Patients.
62
|
Bashir S...Sarin SK
|
29576494 |
2018 |
26 |
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.
62
|
Gleeson M...Cunningham D
|
29703335 |
2018 |
27 |
Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study.
62
|
Roulot D...ANRS HC32 QUATTRO study group
|
29271782 |
2018 |
28 |
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results.
62
|
Spencer A...Richardson P
|
29076150 |
2018 |
29 |
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma.
62
|
Duerinck J...Neyns B
|
28988341 |
2018 |
30 |
Risk of hematologic toxicities with programmed cell death-1 inhibitors in cancer patients: a meta-analysis of current studies.
62
|
Sui JD...Wu YZ
|
29922039 |
2018 |
31 |
Thymus transplantation for complete DiGeorge syndrome: European experience.
62
|
Davies EG...Thrasher AJ
|
28400115 |
2017 |
32 |
A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary.
62
|
Kuronya Z...Geczi L
|
28074331 |
2017 |
33 |
A 15-year single centre retrospective study of antiphospholipid syndrome patients from Northern Malaysia.
62
|
Islam MA...Wong KK
|
28866693 |
2017 |
34 |
Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer.
62
|
Jang J...Shin JW
|
28341958 |
2017 |
35 |
Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes.
62
|
Ong L...Ledgerwood EC
|
27861742 |
2017 |
36 |
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
62
|
Hill P...Webster AC
|
28073178 |
2017 |
37 |
Outcomes of first line chemotherapy in patients with chronic lymphocytic leukemia.
62
|
Nazir A...Hameed A
|
27882024 |
2016 |
38 |
Update: Ongoing Zika Virus Transmission - Puerto Rico, November 1, 2015-July 7, 2016.
62
|
Adams L...Rivera-Garcia B
|
27490087 |
2016 |
39 |
Increased dynamics in the 40-57 Ω-loop of the G41S variant of human cytochrome c promote its pro-apoptotic conformation.
62
|
Karsisiotis AI...Worrall JA
|
27461282 |
2016 |
40 |
Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders.
62
|
Jensen D...HALLMARK-QUAD Study Team
|
25703086 |
2015 |
41 |
Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response.
62
|
Yeo W...Yu SC
|
25962426 |
2015 |
42 |
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study.
62
|
Brana I...Calvo E
|
24928772 |
2015 |
43 |
Non-transient "self-sustaining" heparin-induced thrombocytopenia: 4-year persistence of a platelet-activating PF4/heparin-antibody status without heparin exposure.
62
|
Birschmann I...Koster A
|
24246163 |
2014 |
44 |
Evaluation of the safety of imatinib mesylate in 200 iraqi patients with chronic myeloid leukemia in the chronic phase: single-center study.
62
|
Matti BF...Alwan AF
|
24385829 |
2013 |
45 |
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study.
62
|
Hummel TR...Blaney SM
|
23554030 |
2013 |
46 |
A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors.
62
|
Strosberg JR...Kulke MH
|
23572164 |
2013 |
47 |
Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancer.
62
|
Hubner RA...Chau I
|
23462324 |
2013 |
48 |
Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer.
62
|
Cybulska-Stopa B...Brandys A
|
23788967 |
2013 |
49 |
[Inherited paternal antigens induce pregnancy thrombocytopenia].
62
|
Xia JY...Wu XQ
|
23257447 |
2012 |
50 |
Chemosensitized radiosurgery for recurrent brain metastases.
62
|
Roberge D...Pouliot JF
|
22910852 |
2012 |